All lobbying filings

REVVITY, INC.

Lobbying for REVVITY, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $40,000.00 expenses · posted Jul 13, 2026

Official filing document

Bills named in this filing 3

HR 4709
Newborn Screening Saves Lives Reauthorization Act of 2025
HR 2810
Family Cord Blood Banking Act
S 4612
SCREEN for Type 1 Diabetes Act of 2026

Lobbying activity 1

Health Issues

Diagnostic test reimbursement and policies Proposals related to newborn screening HR 4709 - Newborn Screening Saves Lives Act Reauthorization Act of 2025 H.R. 2810, Family Cord Blood Banking Act S. 4612 SCREEN for Type 1 Diabetes Act Newborn Screening Amendment to NDAA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.